Related Experiment Video
Updated: May 11, 2026

A Murine Model of Group B Streptococcus Vaginal Colonization
Published on: November 16, 2016
Peripartum bacteremia in the era of group B streptococcus prophylaxis
Alison Cape1, Ruth E Tuomala, Chirisse Taylor
1Brigham and Women's Hospital, Division of Maternal-Fetal Medicine, and Channing Laboratory and Department of Newborn Medicine,Harvard Medical School, and the Division of Newborn Medicine, Children's Hospital, Boston, Massachusetts.
Insights
In the era of group B streptococcus prophylaxis, Escherichia coli and enterococci are the most common causes of maternal bacteremia. Group B streptococcus is now rare, accounting for only 4% of peripartum infections.
Area of Science:
- Obstetrics and Gynecology
- Infectious Diseases
- Microbiology
Background:
- Peripartum bacteremia poses significant risks to maternal health.
- Group B Streptococcus (GBS) prophylaxis has altered the landscape of peripartum infections.
- Understanding current microbial epidemiology is crucial for effective management.
Purpose of the Study:
- To define the microbial epidemiology of peripartum bacteremia.
- To identify clinical risk factors associated with peripartum bacteremia.
- To assess the impact of GBS prophylaxis on causative pathogens.
Main Methods:
- Retrospective cohort study of maternal bacteremia from 2000-2008.
- Inclusion criteria: peripartum period (7 days pre- to 30 days post-delivery).
- Chart review to determine clinical factors and outcomes.
Main Results:
- 172 cases of peripartum bacteremia identified (2.2 per 1,000 deliveries).
- Most common pathogens: Escherichia coli (35.9%), enterococci (23.6%), and anaerobes (9.2%).
- GBS accounted for only 4.1% of isolates; endometritis was the most common diagnosis (56%).
Conclusions:
- E. coli and enterococci are now the predominant pathogens in peripartum bacteremia.
- GBS is a rare cause of peripartum bacteremia in the era of prophylaxis.
- Cesarean delivery and preterm birth are significant risk factors for endometritis-associated bacteremia.
Objective:
To define the microbial epidemiology and clinical risk factors associated with peripartum bacteremia in the era of group B streptococcus prophylaxis.
Methods:
We identified all cases of maternal bacteremia occurring during the peripartum time period (defined as from 7 days before delivery until 30 days after delivery) in a large maternity center from 2000 to 2008. Chart review was performed to determine the clinical factors associated with bacteremia.
Results:
During the study period, blood cultures were obtained from 1,295 febrile peripartum women (1.6% of all parturients); 172 of 1,295 febrile peripartum women (13.3%) had bacteremia (2.2 cases per 1,000 deliveries) with 194 microbial isolates and 1 yeast. The most frequent bacterial isolates were Escherichia coli (35.9%), enterococci (23.6%), and anaerobic species (9.2%); group B streptococcus was isolated in only eight cases (4.1%). Clinical diagnoses among infected women included endometritis (56%), chorioamnionitis (21%), and urosepsis (8%). Among women with endometritis, 77% underwent cesarean delivery (compared with vaginal delivery; relative risk [RR] 10.85, 95% confidence interval [CI] 6.75-17.45) and 39% delivered at less than 37 weeks of gestation (compared with 37 weeks or more; RR 3.21, 95% CI 2.42-4.25). Severe maternal complications of bacteremia were noted; six women required intensive care unit admission, five women had development of ileus, and one death occurred because of urosepsis.
Conclusion:
In the era of group B streptococcus prophylaxis, E coli and enterococci are the most frequent bacteria isolated in peripartum bacteremia. Group B streptococcus accounted for only 4% of cases.
Level Of Evidence:
III.
Related Concept Videos
Bacterial Meningitis I: Introduction
Development of the Oral Microbiota
Bacterial Meningitis II: Pathophysiology
Clinical Significance of Antibiotic Resistance
Acute Pyelonephritis II: Diagnostic Studies and Management
Atypical Pneumonia
